Autolus Therapeutics Statistics
NASDAQ: AUTLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.9073-0.0723 (-7.38%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Autolus Therapeutics by the numbers
Autolus Therapeutics has a market capitalization of $241.7 million based on 266.34M shares outstanding. With trailing EPS of $-0.96, Autolus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 43.2% below its 50-day average and 45.0% below its 200-day average.
Average daily trading volume is 2.07M shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AUTL valuation vs. peer median
| Metric | AUTL | Peer median | Difference |
|---|---|---|---|
| Market cap | $241.65M | $249.09M | -3% |
| Avg. volume | 2.07M | 1.44M | +44% |
Peer median across 8 companies: PLX, LXEO, EDIT, SABS, SCTX, EIKN, OCGN, ALLO.
Valuation
- Market cap
- $241.65M
- Price / sales (latest FY)
- 3.21
- EPS (TTM)
- $-0.96
- Shares outstanding
- 266.34M
Price and trading
- Previous close
- 0.9796
- Open
- 0.9641
- Day range
- 0.8963 – 0.9797
- 52-week range
- 0.896 – 2.58
- 52-week change
- -26.24%
- Beta
- —
- Volume
- 3.90M
- Average volume
- 2.07M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 241.65M
- Forward Pe
- -1.60
- Eps
- -0.96
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.58
- Week52 Low
- 0.90
- Avg Volume
- 2.07M
- Shares Outstanding
- 266.34M
- Ma50
- 1.60
- Ma200
- 1.65
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -64.83%
- Pct From52w Low
- 1.26%